SCHEMBL830225

SCHEMBL830225

CCC(N)(CC(=O)O)c1ccc(Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.59
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CYP1A2 P05177 2/20 0.41
LMNA P02545 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
CYP2C19 P33261 2/20 0.39
HIF1A Q16665 1/20 0.39
POLB P06746 1/20 0.39
KIF11 P52732 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1138666 0.86 MIF (0.42) MIFMEN1KMT2ACYP1A2LMNA
SCHEMBL6539846 0.86 ESR1 (0.47) MIFMEN1KMT2ACYP1A2LMNA
SCHEMBL1143912 0.85 CYP2C19 (0.55) MIFMEN1KMT2ACYP1A2MAPT
SCHEMBL1138684 0.85 CYP2C19 (0.55) MIFMEN1KMT2ACYP1A2MAPT
SCHEMBL2298437 0.85 CYP2C19 (0.55) MIFMEN1KMT2ACYP1A2MAPT
SCHEMBL7732423 0.84 MIF (0.41) MIFMEN1KMT2ACYP1A2KDM4E
Hydrochloric Acid SCHEMBL1144491 0.84 CYP2C19 (0.53) MIFMEN1KMT2ACYP1A2MAPT
Hydrochloric Acid SCHEMBL8538776 0.84 CYP2C19 (0.53) MIFMEN1KMT2ACYP1A2MAPT
Hydrochloric Acid SCHEMBL350882 0.84 CYP2C19 (0.53) MIFMEN1KMT2ACYP1A2MAPT
SCHEMBL13749516 0.82 CYP19A1 (0.46) MIFMEN1KMT2ALMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143411-B2 Substituted 6-phenylnicotinic acids and their use BAYER ANIMAL HEALTH GMBH (DE) 2012-03-27 US disclosed
US-20100234432-A1 Substituted 6-phenylnicotinic acids and their use BAYER ANIMAL HEALTH GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234432-A1 Substituted 6-phenylnicotinic acids and their use SLC5A6, FABP3, NAPRT MIF 3404/4885MEN1 3799/4885KMT2A 2444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.